Companies: 10,795·Total market cap: $144.5T
Pulmonx Corporation

Pulmonx Corporation

LUNGNASDAQHealthcare● Active
$1.49
$-0.04(-2.61%)
Market Cap$62933428
P/E Ratio
52W High$3.88
52W Low$1.13
Overview

Pulmonx Corporation (LUNG) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · LUNG · as of Jun 9, 2026

Key Statistics

EPS (TTM)lung eps ttm · lung earnings per shareEarnings history
PE Ratio (TTM)lung pe ratio ttm · lung price to earningsPE Ratio deep dive
Revenue (TTM)lung revenue ttm · lung annual revenueFull revenue history
Dividend YieldNo Dividenddoes lung pay dividends · lung dividend yieldDividend history
Shares Outstandinglung shares outstanding · lung floatShares outstanding history
Next EarningsTBAlung earnings date · lung next earningsEarnings history

About Pulmonx Corporation

CEOGlendon E. French
IPO DateOct 1, 2020
Employees291
CountryUS

Pulmonx Corporation is a biomedical technology firm dedicated to developing and commercializing advanced, less invasive devices for managing chronic obstructive pulmonary diseases. Its primary offerin…

what is pulmonx corporation · lung stock overview · pulmonx corporation company profile · who is pulmonx corporation ceo · lung NASDAQ · pulmonx corporation headquarters · pulmonx corporation business segments

About Stock Overview & Key Data

Pulmonx Corporation (LUNG) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Oct 1, 2020. As of the latest trading session, LUNG stock price is $1.49, with a market capitalization of $62.9M. The stock has returned — over the past 12 months and — year-to-date.

Frequently Asked Questions

As of the latest trading session, Pulmonx Corporation (LUNG) stock price is $1.49. The stock is traded on NASDAQ under the ticker symbol LUNG. The 52-week range is $1.13 – $3.88.

LUNG stock priceLUNG quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice